Session Type
Industry Supported Session
Date
10.06.2022
Session Time
17:55 - 18:55
Room
Conference Room 2.1
Session Description
Practical outpatient management in the era of COVID-19 treatment:
the role of PAXLOVID Supported by Pfizer
the role of PAXLOVID Supported by Pfizer
Session Description:
(▼) This drug is subject to additional follow-up. It is a priority to report suspected adverse reactions associated with this medicinal product.
(▼) Este medicamento está sujeto a seguimiento adicional, es prioritaria la notificación de sospechas de reacciones adversas asociadas a este medicamento.
Practical outpatient management in the era of COVID-19 treatment:
the role of PAXLOVID Supported by Pfizer
Session Type
Industry Supported Session
Date
10.06.2022
Session Time
17:55 - 18:55
Room
Conference Room 2.1
Lecture Time
17:55 - 17:55
Welcome and introduction
Session Type
Industry Supported Session
Date
10.06.2022
Session Time
17:55 - 18:55
Room
Conference Room 2.1
Presenter
Lecture Time
17:55 - 17:55
COVID-19: getting ‘under the skin’ of this complex, multisystemic disease
Session Type
Industry Supported Session
Date
10.06.2022
Session Time
17:55 - 18:55
Room
Conference Room 2.1
Presenter
Lecture Time
17:55 - 17:55
PAXLOVID as a COVID-19 outpatient treatment: what do you need to know?
Session Type
Industry Supported Session
Date
10.06.2022
Session Time
17:55 - 18:55
Room
Conference Room 2.1
Presenter
Lecture Time
17:55 - 17:55
In the clinic: practical COVID-19 patient management
Session Type
Industry Supported Session
Date
10.06.2022
Session Time
17:55 - 18:55
Room
Conference Room 2.1
Presenter
Lecture Time
17:55 - 17:55
Summary and close
Session Type
Industry Supported Session
Date
10.06.2022
Session Time
17:55 - 18:55
Room
Conference Room 2.1
Presenter
Lecture Time
17:55 - 17:55